UK markets open in 6 hours 11 minutes

Creative Medical Technology Holdings, Inc. (CELZ)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.4600+0.1100 (+2.53%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.96M
Enterprise value -4.02M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)687.39
Price/book (mrq)0.58
Enterprise value/revenue -447.19
Enterprise value/EBITDA 0.73

Trading information

Stock price history

Beta (5Y monthly) 5.04
52-week change 3-29.39%
S&P500 52-week change 322.38%
52-week high 310.2812
52-week low 33.9300
50-day moving average 35.0519
200-day moving average 34.8088

Share statistics

Avg vol (3-month) 3218.15k
Avg vol (10-day) 312.23k
Shares outstanding 51.36M
Implied shares outstanding 61.4M
Float 81.32M
% held by insiders 12.71%
% held by institutions 12.66%
Shares short (15 Apr 2024) 423.24k
Short ratio (15 Apr 2024) 41.05
Short % of float (15 Apr 2024) 41.76%
Short % of shares outstanding (15 Apr 2024) 41.71%
Shares short (prior month 15 Mar 2024) 441.47k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 312 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-59,061.30%

Management effectiveness

Return on assets (ttm)-23.49%
Return on equity (ttm)-40.34%

Income statement

Revenue (ttm)9k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-83.90%
Gross profit (ttm)N/A
EBITDA -5.53M
Net income avi to common (ttm)-5.29M
Diluted EPS (ttm)-3.8200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.99M
Total cash per share (mrq)7.36
Total debt (mrq)14.19k
Total debt/equity (mrq)0.14%
Current ratio (mrq)27.66
Book value per share (mrq)7.53

Cash flow statement

Operating cash flow (ttm)-8.03M
Levered free cash flow (ttm)-6.37M